Reliability of extracellular contrast versus gadoxetic acid in assessing small liver lesions using liver imaging reporting and data system v.2018 and European association for the study of the liver criteria-Reference-Cited by-同舟云学术

Reliability of extracellular contrast versus gadoxetic acid in assessing small liver lesions using liver imaging reporting and data system v.2018 and European association for the study of the liver criteria

Published:2022-06-08 Issue:5 Volume:76 Page:1318-1328
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Rimola Jordi¹^ORCID,Sapena Víctor²,Brancatelli Giuseppe³,Darnell Anna¹,Forzenigo Laura⁴,Mähringer‐Kunz Aline⁵,Paisant Anita⁶,Renzulli Matteo⁷^ORCID,Schima Wolfgang⁸,Terraz Sylvain⁹,Valls Carlos¹⁰,Wagner Mathilde¹¹,Ayuso Carmen¹²¹³,Vilgrain Valerie¹⁴¹⁵,Reig Maria¹⁶^ORCID,Ronot Maxime¹⁴¹⁵^ORCID

Affiliation:

1. BCLC Group, Radiology Department Hospital Clínic Barcelona IDIBAPS University of Barcelona Barcelona Spain

2. IDIBAPS, Statistics Core Barcelona Spain

3. Dipartimento di Biomedicina Neuroscienze e Diagnostica avanzata (BIND) University Hospital of Palermo Palermo Italy

4. Radiology Department Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milan Italy

5. Department of Diagnostic and Interventional Radiology University Medical Center Mainz Mainz Germany

6. Radiology Department Angers University Hospital, UNIV Angers, HIFIH, EA Angers France

7. Department of Radiology IRCCS Azienda Ospedaliero‐Universitaria di Bologna Bologna Italy

8. Department of Diagnostic and Interventional Radiology Barmherzige Schwestern Krankenhaus, and Sankt Josef Krankenhaus Göttlicher Heiland Krankenhaus Vienna Austria

9. Department of Radiology Hepato‐Pancreato‐Biliary Centre, University Hospitals of Geneva Geneva Switzerland

10. Department of Radiology Karolinska University Hospital, Division of Radiology, CLINTEC, Karolinska Institutet Stockholm Sweden

11. Sorbonne Université, INSERM, CNRS, LIB, Department of Radiology Hôpitaux Universitaires Pitié‐Salpêtrière–Charles Foix APHP Paris France

12. BCLC Group, Radiology Department Hospital Clínic Barcelona Barcelona Spain

13. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) University of Barcelona, IDIBAPS Barcelona Spain

14. Department of Radiology Hopital Beaujon, APHP. Nord Clichy France

15. Université de Paris, CRI, INSERM Paris France

16. BCLC Group, Liver Unit Hospital Clínic Barcelona University of Barcelona IDIBAPS Barcelona Spain

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32494

Reference26 articles.

1. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

2. Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients

3. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

4. Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy—A Systematic Review

5. Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCs

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ESR Bridges: imaging and treatment of hepatocellular carcinoma—a multidisciplinary view;European Radiology;2024-03-15

2. ESR Essentials: diagnosis of hepatocellular carcinoma—practice recommendations by ESGAR;European Radiology;2024-02-21

3. From evidence to clinical practice: Bridging the gap of new liver cancer therapies in Latin America.;Annals of Hepatology;2023-12

4. Correction of Arterial-Phase Motion Artifacts in Gadoxetic Acid-Enhanced Liver MRI Using an Innovative Unsupervised Network;Bioengineering;2023-10-13

5. Evaluation of washout using subtraction MRI for the diagnosis of hepatocellular carcinoma in cirrhotic patients with spontaneously T1-hyperintense nodules;Diagnostic and Interventional Imaging;2023-09